Please wait a minute...
Shopping Cart Email List Chinese
Advanced Search Fig/Tab
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Featured Articles  |  Most Downloaded  |  Most Reading
Online Submission Subscribe to Our RSS Content Feed
Front. Med.    2020, Vol. 14 Issue (2) : 215-219    https://doi.org/10.1007/s11684-020-0766-9
COMMENTARY
COVID-19 containment: China provides important lessons for global response
Shuxian Zhang1, Zezhou Wang2, Ruijie Chang1, Huwen Wang1, Chen Xu1, Xiaoyue Yu1, Lhakpa Tsamlag1, Yinqiao Dong3, Hui Wang1(), Yong Cai1()
1. School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
2. Department of Cancer Prevention, Shanghai Cancer Center, Fudan University, Shanghai 200032, China
3. Department of Environmental and Occupational Health, School of Public Health, China Medical University, Shenyang 110122, China
 Download: PDF(88 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

The world must act fast to contain wider international spread of the epidemic of COVID-19 now. The unprecedented public health efforts in China have contained the spread of this new virus. Measures taken in China are currently proven to reduce human-to-human transmission successfully. We summarized the effective intervention and prevention measures in the fields of public health response, clinical management, and research development in China, which may provide vital lessons for the global response. It is really important to take collaborative actions now to save more lives from the pandemic of COVID-19.
Keywords coronavirus disease 2019 (COVID-19)      control measure      public health response     
Corresponding Author(s): Hui Wang,Yong Cai   
Just Accepted Date: 09 March 2020   Online First Date: 24 March 2020    Issue Date: 09 May 2020
 Cite this article:   
Shuxian Zhang,Zezhou Wang,Ruijie Chang, et al. COVID-19 containment: China provides important lessons for global response[J]. Front. Med., 2020, 14(2): 215-219.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-020-0766-9
https://academic.hep.com.cn/fmd/EN/Y2020/V14/I2/215
1 WHO. Coronavirus disease 2019 (covid-19) situation. report-47. March 7, 2020.
2 The National Health Commission of the People’s Republic of China. Report on 2019- nCoV. March 8, 2020.
3 WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020.
4 The Health Commission of Wuhan. 41 COVID-19 patients were confirmed in Wuhan. January 11, 2020. (in Chinese)
5 Hubei Provincial Government. Notice on Wuhan novel coronavirus infection of pneumonia epidemic prevention and control. January 23, 2020.(in Chinese)
6 The Ministry of Finance and the National Health Commission of the People’s Republic of China. China issues 9.95b yuan additional funds for public health, epidemic control. January 28, 2020.
7 The State Council of the People’s Republic of China. The notice on orderly resuming production and resuming production in enterprises. February 9, 2020. (in Chinese)
8 The National Development and Reform Commission of the People’s Republic of China. China’s daily mask output exceeds 110 million units. March 7, 2020.
9 H Wang, Z Wang, Y Dong, R Chang, C Xu, X Yu, S Zhang, L Tsamlag, M Shang, J Huang, Y Wang, G Xu, T Shen, X Zhang, Y Cai. Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discov 2020; 6(1): 10
https://doi.org/10.1038/s41421-020-0148-0 pmid: 32133152
10 Wuhan Municipal Government.Wuhan Huoshenshan Hospital was completed today. February 2, 2020.(in Chinese)
11 Hubei Provincial Government. Wuhan Leishenshan Hospital welcomed its first confirmed 2019-nCoV patients. February 9, 2020. (in Chinese)
12 The State Council. Press Conference of the joint Prevention and Control Mechanism of the State Council. March 6, 2020.(in Chinese)
13 General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine. Diagnostic and treatment protocol for novel coronavirus pneumonia (Trial version 7). March 4, 2020.(in Chinese)
14 P Zhou, XL Yang, XG Wang, B Hu, L Zhang, W Zhang, HR Si, Y Zhu, B Li, CL Huang, HD Chen, J Chen, Y Luo, H Guo, RD Jiang, MQ Liu, Y Chen, XR Shen, X Wang, XS Zheng, K Zhao, QJ Chen, F Deng, LL Liu, B Yan, FX Zhan, YY Wang, GF Xiao, ZL Shi. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 Feb 3. [Epub ahead of print] doi: 10.1038/s41586-020-2012-7
https://doi.org/10.1038/s41586-020-2012-7 pmid: 32015507
15 N Zhu, D Zhang, W Wang, X Li, B Yang, J Song, X Zhao, B Huang, W Shi, R Lu, P Niu, F Zhan, X Ma, D Wang, W Xu, G Wu, GF Gao, W Tan; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727–733
https://doi.org/10.1056/NEJMoa2001017 pmid: 31978945
16 R Lu, X Zhao, J Li, P Niu, B Yang, H Wu, W Wang, H Song, B Huang, N Zhu, Y Bi, X Ma, F Zhan, L Wang, T Hu, H Zhou, Z Hu, W Zhou, L Zhao, J Chen, Y Meng, J Wang, Y Lin, J Yuan, Z Xie, J Ma, WJ Liu, D Wang, W Xu, EC Holmes, GF Gao, G Wu, W Chen, W Shi, W Tan. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224): 565–574
https://doi.org/10.1016/S0140-6736(20)30251-8 pmid: 32007145
17 C Huang, Y Wang, X Li, L Ren, J Zhao, Y Hu, L Zhang, G Fan, J Xu, X Gu, Z Cheng, T Yu, J Xia, Y Wei, W Wu, X Xie, W Yin, H Li, M Liu, Y Xiao, H Gao, L Guo, J Xie, G Wang, R Jiang, Z Gao, Q Jin, J Wang, B Cao. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497–506
https://doi.org/10.1016/S0140-6736(20)30183-5 pmid: 31986264
18 Q Li, X Guan, P Wu, X Wang, L Zhou, Y Tong, R Ren, KSM Leung, EHY Lau, JY Wong, X Xing, N Xiang, Y Wu, C Li, Q Chen, D Li, T Liu, J Zhao, M Liu, W Tu, C Chen, L Jin, R Yang, Q Wang, S Zhou, R Wang, H Liu, Y Luo, Y Liu, G Shao, H Li, Z Tao, Y Yang, Z Deng, B Liu, Z Ma, Y Zhang, G Shi, TTY Lam, JTK Wu, GF Gao, BJ Cowling, B Yang, GM Leung, Z Feng. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020 Jan 29. [Epub ahead of print] doi: 10.1056/NEJMoa2001316
https://doi.org/10.1056/NEJMoa2001316 pmid: 31995857
19 Z Wu, JM McGoogan. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 Feb 24. [Epub ahead of print] doi: 10.1001/jama.2020.2648
https://doi.org/10.1001/jama.2020.2648 pmid: 32091533
20 G Li, E De Clercq. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020; 19(3): 149–150
https://doi.org/10.1038/d41573-020-00016-0 pmid: 32127666
21 B Tang, X Wang, Q Li, NL Bragazzi, S Tang, Y Xiao, J Wu. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med 2020; 9(2): 462
22 J Li, Y Wang, S Gilmour, et al.. Estimation of the epidemic properties of the 2019 novel coronavirus: a mathematical modeling study. medRxiv 2020; doi: 10.1101/2020.02.18.20024315
https://doi.org/10.1101/2020.02.18.20024315
23 The Chinese Center for Disease Control and Prevention. China CDC publishes multilingual epidemic control manuals for COVID-19. March 2, 2020.
[1] Dongsheng Wang, Binqing Fu, Zhen Peng, Dongliang Yang, Mingfeng Han, Min Li, Yun Yang, Tianjun Yang, Liangye Sun, Wei Li, Wei Shi, Xin Yao, Yan Ma, Fei Xu, Xiaojing Wang, Jun Chen, Daqing Xia, Yubei Sun, Lin Dong, Jumei Wang, Xiaoyu Zhu, Min Zhang, Yonggang Zhou, Aijun Pan, Xiaowen Hu, Xiaodong Mei, Haiming Wei, Xiaoling Xu. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial[J]. Front. Med., 2021, 15(3): 486-494.
[2] Zhengqian Li, Taotao Liu, Ning Yang, Dengyang Han, Xinning Mi, Yue Li, Kaixi Liu, Alain Vuylsteke, Hongbing Xiang, Xiangyang Guo. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain[J]. Front. Med., 2020, 14(5): 533-541.
[3] Lingling Tang, Yingan Jiang, Mengfei Zhu, Lijun Chen, Xiaoyang Zhou, Chenliang Zhou, Peng Ye, Xiaobei Chen, Baohong Wang, Zhenyu Xu, Qiang Zhang, Xiaowei Xu, Hainv Gao, Xiaojun Wu, Dong Li, Wanli Jiang, Jingjing Qu, Charlie Xiang, Lanjuan Li. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19[J]. Front. Med., 2020, 14(5): 664-673.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed